De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv

De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv Publisher Pubmed

Saffarian Z^{1, 2} ; Samii R² ; Ghanadan A³ ; Vahidnezhad H^{4, 5}

Show Affiliations

1. Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States
5. Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, United States

Source: Dermatologic Therapy Published:2022

Abstract

[No abstract available]

Related Docs

1. Cutaneous Manifestations Following Covid-19 Vaccination: A Report of 25 Cases, Dermatologic Therapy (2022)

2. Association of Alternative Healthy Eating Index and Severity of Pemphigus Vulgaris: A Crosssectional Study, PLoS ONE (2023)

3. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed Covid-19 Vaccine-Related Dermatologic Manifestations, American Journal of Dermatopathology (2023)

4. Interesting Mucocutaneous Manifestations in Covid-19 Infection or Vaccination Confirmed by Histopathology: A Case Series, Case Reports in Dermatology (2024)

5. High Dietary Acid Load Predicts Severity of Autoimmune Skin Disease: A Cross-Sectional Study, Scientific Reports (2024)

6. Single-Nucleotide Polymorphisms Associated With Pemphigus Vulgaris: Potent Markers for Better Treatment and Personalized Medicine, International Journal of Immunogenetics (2020)

7. Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients, Dermatologic Therapy (2022)

Experts (# of related papers)

View all Related Experts

Maryam Daneshpajooh (3)

Kamran Balighi (3)

Style	Citing Format
MLA	Saffarian Z, et al.. "De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv." Dermatologic Therapy, vol. 35, no. 6, 2022, pp. -.
APA	Saffarian Z, Samii R, Ghanadan A, Vahidnezhad H (2022). De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv. Dermatologic Therapy, 35(6), -.
Chicago	Saffarian Z, Samii R, Ghanadan A, Vahidnezhad H. "De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv." Dermatologic Therapy 35, no. 6 (2022): -.
Harvard	Saffarian Z et al. (2022) 'De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv', Dermatologic Therapy, 35(6), pp. -.
Vancouver	Saffarian Z, Samii R, Ghanadan A, Vahidnezhad H. De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv. Dermatologic Therapy. 2022;35(6):-.
BibTex	@article{ author = {Saffarian Z and Samii R and Ghanadan A and Vahidnezhad H}, title = {De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv}, journal = {Dermatologic Therapy}, volume = {35}, number = {6}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Saffarian Z AU - Samii R AU - Ghanadan A AU - Vahidnezhad H TI - De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv JO - Dermatologic Therapy VL - 35 IS - 6 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract